Wataru Matsuyama

1.8k total citations
46 papers, 896 citations indexed

About

Wataru Matsuyama is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Wataru Matsuyama has authored 46 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Wataru Matsuyama's work include T-cell and Retrovirus Studies (5 papers), Viral Infections and Immunology Research (5 papers) and Hereditary Neurological Disorders (4 papers). Wataru Matsuyama is often cited by papers focused on T-cell and Retrovirus Studies (5 papers), Viral Infections and Immunology Research (5 papers) and Hereditary Neurological Disorders (4 papers). Wataru Matsuyama collaborates with scholars based in Japan, United States and Poland. Wataru Matsuyama's co-authors include Mitsuhiro Osame, Kimiyoshi Arimura, Masaharu Kawabata, Teizo Yoshimura, Teruto Hashiguchi, Hidenobu Kamohara, Hiroshi Takashima, Masanori Nakagawa, Akira Mizoguchi and Michel Faure and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Wataru Matsuyama

45 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wataru Matsuyama Japan 19 235 232 199 123 110 46 896
D Woodrow United Kingdom 22 343 1.5× 352 1.5× 81 0.4× 185 1.5× 130 1.2× 49 1.1k
Holger Link United States 5 256 1.1× 256 1.1× 311 1.6× 103 0.8× 82 0.7× 10 845
M Rose United Kingdom 15 600 2.6× 257 1.1× 107 0.5× 100 0.8× 186 1.7× 23 1.2k
Donald J. McCrann United States 14 110 0.5× 216 0.9× 95 0.5× 53 0.4× 80 0.7× 31 728
Pamela J. Daffern United States 12 512 2.2× 128 0.6× 141 0.7× 60 0.5× 65 0.6× 13 953
Daniela Giachino Italy 19 203 0.9× 740 3.2× 322 1.6× 202 1.6× 125 1.1× 51 1.6k
Xiaobo Wu United States 23 853 3.6× 231 1.0× 157 0.8× 123 1.0× 100 0.9× 36 1.4k
Brigitte Strahm Germany 24 439 1.9× 499 2.2× 152 0.8× 193 1.6× 65 0.6× 78 1.7k
Fred G. Pluthero Canada 22 775 3.3× 344 1.5× 181 0.9× 56 0.5× 110 1.0× 48 1.6k
Chad K. Oh United States 19 575 2.4× 225 1.0× 486 2.4× 83 0.7× 134 1.2× 34 1.5k

Countries citing papers authored by Wataru Matsuyama

Since Specialization
Citations

This map shows the geographic impact of Wataru Matsuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Matsuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Matsuyama more than expected).

Fields of papers citing papers by Wataru Matsuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Matsuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Matsuyama. The network helps show where Wataru Matsuyama may publish in the future.

Co-authorship network of co-authors of Wataru Matsuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Matsuyama. A scholar is included among the top collaborators of Wataru Matsuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Matsuyama. Wataru Matsuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogasawara, Takashi, Naoto Nakamura, Wataru Matsuyama, et al.. (2023). The effect of 1-hydroxy-vitamin D treatment in hospitalized patients with COVID-19: A retrospective study. Clinical Nutrition. 42(10). 2045–2050. 1 indexed citations
2.
3.
Kumamoto, Tomohiro, Tetsuhiko Taira, Satoshi Noma, et al.. (2007). [A possible case of drug-induced pneumonia due to L-carbocisteine].. PubMed. 45(8). 609–14. 4 indexed citations
4.
Matsuyama, Wataru, et al.. (2006). [A case of bronchiolitis obliterans syndrome successfully treated by Tiotropium bromide].. PubMed. 44(5). 404–9. 1 indexed citations
5.
Matsuyama, Wataru, Hideo Mitsuyama, Masaki Watanabe, et al.. (2006). [Two lung adenocarcinoma patients with multiple brain metastasis treated with Gefitinib and surviving more than 2 years].. PubMed. 44(9). 653–8. 3 indexed citations
6.
Okamoto, Yuji, Hiroshi Takashima, Itsuro Higuchi, et al.. (2006). Molecular mechanism of rigid spine with muscular dystrophy type 1 caused by novel mutations of selenoprotein N gene. Neurogenetics. 7(3). 175–183. 24 indexed citations
7.
Matsuyama, Wataru, Ikkou Higashimoto, Masaki Watanabe, et al.. (2005). Living-donor Lobar Lung Transplantation in Sauropus androgynus-associated Bronchiolitis Obliterans in Japan. Internal Medicine. 44(10). 1103–1104. 3 indexed citations
8.
Yoshimura, Teizo, Wataru Matsuyama, & Hidenobu Kamohara. (2005). Discoidin Domain Receptor 1: A New Class of Receptor Regulating Leukocyte-Collagen Interaction. Immunologic Research. 31(3). 219–230. 37 indexed citations
9.
Matsuyama, Wataru, Lihua Wang, William L. Farrar, Michel Faure, & Teizo Yoshimura. (2004). Activation of Discoidin Domain Receptor 1 Isoform b with Collagen Up-Regulates Chemokine Production in Human Macrophages: Role of p38 Mitogen-Activated Protein Kinase and NF-κB. The Journal of Immunology. 172(4). 2332–2340. 80 indexed citations
10.
Matsuyama, Wataru, et al.. (2004). [Intense 18F-fluorodeoxyglucose uptake caused by pulmonary Mycobacterium intracellulare infection].. PubMed. 42(11). 970–4. 1 indexed citations
11.
Takashima, Hiroshi, M. Nakagawa, Fujio Umehara, et al.. (2003). Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot-Marie-Tooth disease. Acta Neurologica Scandinavica. 107(1). 31–37. 29 indexed citations
12.
Matsuyama, Wataru, et al.. (2003). Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis − HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity. Clinical & Experimental Immunology. 133(3). 397–403. 18 indexed citations
13.
Matsuyama, Wataru, Masanori Nakagawa, Hiroshi Takashima, & Mitsuhiro Osame. (2002). Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B. Acta Neuropathologica. 103(5). 501–508. 15 indexed citations
14.
Matsuyama, Wataru, et al.. (2002). Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respiratory Medicine. 96(10). 817–822. 42 indexed citations
15.
Matsuyama, Wataru, Teruto Hashiguchi, Fujio Umehara, et al.. (2001). Expression of vascular endothelial growth factor in tuberculous meningitis. Journal of the Neurological Sciences. 186(1-2). 75–79. 37 indexed citations
16.
17.
Matsuyama, Wataru, Teruto Hashiguchi, Kenji Matsumuro, et al.. (2000). Increased Serum Level of Vascular Endothelial Growth Factor in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 162(3). 1120–1122. 81 indexed citations
18.
Matsuyama, Wataru, Teruto Hashiguchi, Akira Mizoguchi, et al.. (2000). Serum Levels of Vascular Endothelial Growth Factor Dependent on the Stage Progression of Lung Cancer. CHEST Journal. 118(4). 948–951. 72 indexed citations
19.
20.
Matsuyama, Wataru, Joeji Wakimoto, Akira Watanabe, et al.. (1999). Bronchiectasis with Myeloperoxidase Antineutrophil Cytoplasmic Antibody and Bactericidal/Permeability-Increasing Protein Antineutrophil Cytoplasmic Antibody.. Internal Medicine. 38(10). 813–816. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Woodrow Breakdown of academic impact, for papers by Holger Link Breakdown of academic impact, for papers by M Rose Breakdown of academic impact, for papers by Donald J. McCrann Breakdown of academic impact, for papers by Pamela J. Daffern Breakdown of academic impact, for papers by Daniela Giachino Breakdown of academic impact, for papers by Xiaobo Wu Breakdown of academic impact, for papers by Brigitte Strahm Breakdown of academic impact, for papers by Fred G. Pluthero Breakdown of academic impact, for papers by Chad K. Oh
Rankless by CCL
2026